| Applications of π-π stacking interactions in the design of drug-delivery systems WR Zhuang, Y Wang, PF Cui, L Xing, J Lee, D Kim, HL Jiang, YK Oh Journal of controlled release 294, 311-326, 2019 | 320 | 2019 |
| Therapeutic gene editing: delivery and regulatory perspectives G Shim, D Kim, GT Park, H Jin, SK Suh, YK Oh Acta Pharmacologica Sinica 38 (6), 738-753, 2017 | 140 | 2017 |
| Functional regulation of FoxO1 in neural stem cell differentiation DY Kim, I Hwang, FL Muller, JH Paik Cell Death & Differentiation 22 (12), 2034-2045, 2015 | 90 | 2015 |
| Nanocomplex‐mediated in vivo programming to chimeric antigen receptor‐M1 macrophages for cancer therapy M Kang, SH Lee, M Kwon, J Byun, D Kim, C Kim, S Koo, SP Kwon, ... Advanced materials 33 (43), 2103258, 2021 | 89 | 2021 |
| Nanoformulation-based sequential combination cancer therapy G Shim, MG Kim, D Kim, JY Park, YK Oh Advanced drug delivery reviews 115, 57-81, 2017 | 83 | 2017 |
| Nonviral delivery systems for cancer gene therapy: strategies and challenges G Shim, D Kim, QV Le, GT Park, T Kwon, YK Oh Current gene therapy 18 (1), 3-20, 2018 | 78 | 2018 |
| Light-switchable systems for remotely controlled drug delivery G Shim, S Ko, D Kim, QV Le, GT Park, J Lee, T Kwon, HG Choi, YB Kim, ... Journal of controlled release 267, 67-79, 2017 | 74 | 2017 |
| Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics MG Kim, D Kim, SK Suh, Z Park, MJ Choi, YK Oh Archives of pharmacal research 39, 437-452, 2016 | 39 | 2016 |
| Nanoparticle-mediated lipid metabolic reprogramming of T cells in tumor microenvironments for immunometabolic therapy D Kim, Y Wu, Q Li, YK Oh Nano-Micro Letters 13, 1-27, 2021 | 35 | 2021 |
| Nanovesicle-mediated delivery systems for CRISPR/Cas genome editing D Kim, QV Le, Y Wu, J Park, YK Oh Pharmaceutics 12 (12), 1233, 2020 | 34 | 2020 |
| In vivo fate and intracellular trafficking of vaccine delivery systems J Lee, D Kim, J Byun, Y Wu, J Park, YK Oh Advanced Drug Delivery Reviews 186, 114325, 2022 | 31 | 2022 |
| Tannic acid-functionalized boron nitride nanosheets for theranostics G Shim, S Ko, JY Park, JH Suh, QV Le, D Kim, YB Kim, GH Im, HN Kim, ... Journal of Controlled Release 327, 616-626, 2020 | 30 | 2020 |
| Biomimetic polymeric nanoparticle-based photodynamic immunotherapy and protection against tumor rechallenge D Kim, J Byun, J Park, Y Lee, G Shim, YK Oh Biomaterials science 8 (4), 1106-1116, 2020 | 30 | 2020 |
| Advances in vaccine delivery systems against viral infectious diseases D Kim, Y Wu, YB Kim, YK Oh Drug Delivery and Translational Research 11, 1401-1419, 2021 | 29 | 2021 |
| Safety and photochemotherapeutic application of poly (γ-glutamic acid)-based biopolymeric nanoparticle D Kim, QV Le, YB Kim, YK Oh Acta Pharmaceutica Sinica B 9 (3), 565-574, 2019 | 22 | 2019 |
| Genome-editing-mediated restructuring of tumor immune microenvironment for prevention of metastasis D Kim, Y Wu, G Shim, YK Oh ACS nano 15 (11), 17635-17656, 2021 | 20 | 2021 |
| Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy H Ju, D Kim, YK Oh Asian journal of pharmaceutical sciences 17 (5), 641-652, 2022 | 16 | 2022 |
| Staphylococcus aureus-mimetic control of antibody orientation on nanoparticles G Shim, D Kim, S Lee, RS Chang, J Byun, YK Oh Nanomedicine: Nanotechnology, Biology and Medicine 16, 267-277, 2019 | 16 | 2019 |
| Lipid nanoparticle-mediated lymphatic delivery of immunostimulatory nucleic acids D Kim, Y Wu, G Shim, YK Oh Pharmaceutics 13 (4), 490, 2021 | 14 | 2021 |
| In vivo therapeutic genome editing via CRISPR/Cas9 magnetoplexes for myocardial infarction H Park, D Kim, B Cho, J Byun, YS Kim, Y Ahn, J Hur, YK Oh, J Kim Biomaterials 281, 121327, 2022 | 12 | 2022 |
